USD 134.03
(-6.35%)
Breakdown | 2023 | 2023 | 2022 | 2021 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 477 Million | 392 Million | 545 Million | 1.08 Billion | 1.05 Billion | 1.14 Billion |
Net Income | -1.16 Billion | -4.4 Billion | 762 Million | 656 Million | 990 Million | 782 Million |
Depreciation & Amortization | 432 Million | 394 Million | 251 Million | 187 Million | 188 Million | 179 Million |
Deferred income taxes | -33 Million | -23 Million | -76 Million | 117 Million | 11 Million | -18 Million |
Stock-based compensation | 380 Million | 366 Million | 754 Million | 194 Million | 194 Million | 193 Million |
Change in working capital | -90 Million | 204 Million | -152 Million | 73 Million | -194 Million | -18 Million |
Other non-cash items | 949 Million | 3.85 Billion | -994 Million | -147 Million | -138 Million | 24 Million |
Investing Cash Flow | -231 Million | -591 Million | -1.06 Billion | -554 Million | 745 Million | -1.81 Billion |
Investments in PPE | -196 Million | -466 Million | -208 Million | -189 Million | -209 Million | -296 Million |
Acquisitions | -29 Million | -85 Million | -2.44 Billion | -98 Million | -32 Million | -100 Million |
Investment purchases | -6 Million | -40 Million | -129 Million | -1.92 Billion | -1.03 Billion | -2.87 Billion |
Sales/Maturities of investments | 36 Million | 180 Million | 1.71 Billion | 1.79 Billion | 2.01 Billion | 1.45 Billion |
Other Investing Activities | -36 Million | -180 Million | 1.58 Billion | -132 Million | -18 Million | -1.41 Billion |
Financing Cash Flow | -1.2 Billion | 1 Billion | -51 Million | -766 Million | -897 Million | 594 Million |
Debt repayment | -1.23 Billion | -991 Million | -517 Million | - | -550 Million | -4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -40 Million | -54 Million | -511 Million | -736 Million | -324 Million | -201 Million |
Common Stock Issuance | 67 Million | 63 Million | 60 Million | 61 Million | 59 Million | 46 Million |
Other Financing Activities | -41 Million | 2.91 Billion | 1.42 Billion | -91 Million | -82 Million | 1.48 Billion |
Accounts receivables | -40 Million | -12 Million | -164 Million | 89 Million | -58 Million | -105 Million |
Accounts payables | -44 Million | -38 Million | 60 Million | 40 Million | -35 Million | 45 Million |
Inventory | -20 Million | -135 Million | -58 Million | -12 Million | 25 Million | -53 Million |
Other working capital | 14 Million | 389 Million | 10 Million | -44 Million | -126 Million | 95 Million |
Cash at beginning of period | 2.01 Billion | 1.23 Billion | 1.81 Billion | 2.04 Billion | 1.14 Billion | 1.22 Billion |
Cash at end of period | 1.04 Billion | 2.01 Billion | 1.23 Billion | 1.81 Billion | 2.04 Billion | 1.14 Billion |
Capital Expenditure | -196 Million | -466 Million | -208 Million | -189 Million | -209 Million | -296 Million |
Effect of forex changes on cash | - | -22 Million | -3 Million | 8 Million | -1 Million | -4 Million |
Net cash flow / Change in cash | -963 Million | 779 Million | -578 Million | -232 Million | 898 Million | -81 Million |
Free Cash Flow | 281 Million | -74 Million | 337 Million | 891 Million | 842 Million | 846 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.11 Billion | -1.98 Billion | -126 Million | -176 Million | -1.16 Billion | -3.81 Billion |
Depreciation & Amortization | -213 Million | 105 Million | 108 Million | 107 Million | 432 Million | 108 Million |
Deferred income taxes | 180 Million | -156 Million | -24 Million | 9 Million | -33 Million | 9 Million |
Stock-based compensation | -208 Million | 112 Million | 96 Million | 94 Million | 380 Million | 87 Million |
Change in working capital | -56 Million | 82 Million | -26 Million | 78 Million | -90 Million | 1 Million |
Other non-cash items | -1.5 Billion | 2.25 Billion | 304 Million | 111 Million | 949 Million | 3.75 Billion |
Investing Cash Flow | -41 Million | -41 Million | -48 Million | -85 Million | -231 Million | -54 Million |
Investments in PPE | -32 Million | -31 Million | -36 Million | -51 Million | -196 Million | -45 Million |
Acquisitions | - | - | - | -29 Million | -29 Million | - |
Investment purchases | 22 Million | -10 Million | -12 Million | 13 Million | -6 Million | -8 Million |
Sales/Maturities of investments | - | - | - | -18 Million | 36 Million | - |
Other Investing Activities | -31 Million | -9 Million | -48 Million | -5 Million | -36 Million | -1 Million |
Financing Cash Flow | -332 Million | -226 Million | 35 Million | -26 Million | -1.2 Billion | -707 Million |
Debt repayment | -744 Million | -744 Million | - | - | -1.23 Billion | -735 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | 2 Million | -1 Million | -1 Million | -26 Million | -40 Million | -2 Million |
Common Stock Issuance | -36 Million | - | 36 Million | - | 67 Million | 30 Million |
Other Financing Activities | 446 Million | -970 Million | -1 Million | -26 Million | -41 Million | -2 Million |
Accounts receivables | -72 Million | -18 Million | 90 Million | -9 Million | -40 Million | 47 Million |
Accounts payables | 30 Million | 7 Million | -37 Million | 6 Million | -44 Million | -6 Million |
Inventory | -4 Million | - | 4 Million | 27 Million | -20 Million | 2 Million |
Other working capital | -10 Million | 93 Million | -83 Million | 54 Million | 14 Million | -42 Million |
Cash at beginning of period | 920 Million | 1.1 Billion | 1.04 Billion | 927 Million | 2.01 Billion | 1.55 Billion |
Cash at end of period | 869 Million | 920 Million | 1.1 Billion | 1.04 Billion | 1.04 Billion | 927 Million |
Capital Expenditure | -32 Million | -31 Million | -36 Million | -51 Million | -196 Million | -45 Million |
Effect of forex changes on cash | 6 Million | -1 Million | -4 Million | 9 Million | - | -4 Million |
Net cash flow / Change in cash | -51 Million | -188 Million | 60 Million | 121 Million | -963 Million | -626 Million |
Free Cash Flow | 284 Million | 49 Million | 41 Million | 172 Million | 281 Million | 94 Million |
300088
KOPY
CMPY
MINOLTAF
IFC-PG
002337